How we helped a large MNC speed up the launch of a new hand sanitizers product.
With increasing consumer demand for hand sanitizers as a direct result of the COVID-19 pandemic, manufacturers are looking for guidance on securing approval of on-pack claims. In response, regulators enacted temporary policies to bolster the availability of alcohol-based sanitizer, but are not willing to sacrifice consumer safety. Sanitizers marketed with unapproved claims face regulatory scrutiny.
Objective:
During the outbreak, a sizeable multi-national corporation specializing in household cleaners approached RegASK in anticipation of a new product launch. The client wished to understand the global regulatory requirements for approval of a claim reading: “kills 99% of germs.”
Approach:
RegASK worked quickly to analyze the differences in regulatory requirements across US, EU and Asia. Regulatory experts leveraged proprietary digital technology to identify the correct product classification for each market, determining whether OTC, biocide, or medical device was more appropriate, depending on the differing national and regional definitions.
Result:
RegASK’s solutions provided the client comprehensive insight into the regulatory differences between the chosen markets, ensuring the success of the product launches in each region. The findings gave the client the necessary confidence to move forward with registration.
